SRRASudan Relief and Rehabilitation Association
SRRAStrategic Rail Research Agenda (European Rail Research Advisory Council)
SRRASouth Ruislip Residents Association (UK)
SRRASimultaneous Routing and Resource Allocation
SRRASan Rafael Resource Area (Utah)
SRRASage Race Relations Abstracts (journal)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
"The representation office and the liaison offices of the SRRA regret and rejects the accident in which around 10 humanitarian agencies offices and compounds, as well as the commission for refugee affairs CRA, have been attacked and destroyed," said a statement signed by SRRA Executive Director and the group's Representative to EU countries and the UN Mohamed Yassin.
The SPLM has a highly developed relief operation under the Sudan Relief and Rehabilitation Association, the SRRA, with a wide array of education, health, and development programs in the south.
Finally their Sudanese counterparts in the Sudan Relief and Rehabilitation Authority (SRRA) have ideological and other difficulties of their own to contend with within the administration.
To safeguard NGO staff in what is a dangerous environment and to ensure that at least a semblance of the aid reaches the desperate populations, the NGO's in the southern Sudan agreed to 'prior approval' and 'security services' arrangements with both the Khartoum government and the SPLA's Sudan Relief and Rehabilitation Association (SRRA), the rebel's conveniently labelled 'humanitarian' wing.
ALSO HIGHER: Sierra Oncology (SRRA) up 5.3% after reporting pre-clinical efficacy with SRA737...
September 8, 2017 (KHARTOUM) - The humanitarian branch of the SPLM-N al-Hilu SPLM's Sudan Relief and Rehabilitation Association (SRRA) called on the international community to investigate "attacks on civilians" by a rival group led by Malik Agar in the Blue Nile state.
SRRA, the Site Remediation Reform Act, promulgated in 2009 and mandatory in 2012.
Sierra Oncology (SRRA) announced it has acquired the drug candidate momelotinib from Gilead Sciences (GILD).
(NASDAQ: SRRA) has reported preclinical data supporting the ongoing clinical development strategy for its Chk1 inhibitor, SRA737, the company said.